Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
16001
Low efficiency induction of neural rosette-like cells from the hESCs CHA13 and CHA15 using a previously published stromal cell co-culture method.
Published 2015“…(B-E) Morphology of H9 (B), HSF6 (C), CAH13 (D), and CHA15 (E) cells under neural induction (stage I) conditions (on γ-irradiated MS5 feeder layer in ITS+AA medium). H9 and HSF6 cells formed neural rosette structures with a neuroepithelial cell morphology (arrows in B and C). …”
-
16002
-
16003
-
16004
-
16005
-
16006
-
16007
-
16008
In Situ Deactivation of Catechol-Containing Adhesive Using Electrochemistry
Published 2020“…Johnson–Kendall–Roberts (JKR) contact mechanics test was performed using a titanium (Ti) sphere in the presence of a pH 7.5 aqueous buffer. …”
-
16009
In Situ Deactivation of Catechol-Containing Adhesive Using Electrochemistry
Published 2020“…Johnson–Kendall–Roberts (JKR) contact mechanics test was performed using a titanium (Ti) sphere in the presence of a pH 7.5 aqueous buffer. …”
-
16010
In Situ Deactivation of Catechol-Containing Adhesive Using Electrochemistry
Published 2020“…Johnson–Kendall–Roberts (JKR) contact mechanics test was performed using a titanium (Ti) sphere in the presence of a pH 7.5 aqueous buffer. …”
-
16011
-
16012
-
16013
Treatment with APB5, but not APA5 attenuates pulmonary fibrosis in BLM-treated mice.
Published 2018“…<p>BLM was injected subcutaneously with a mini-osmotic pump for 7 days. APA5, APB5, and IgG as a control were injected intraperitoneally every other day from the start on Day 0 to sacrifice on Day 28. …”
-
16014
-
16015
-
16016
-
16017
-
16018
-
16019
-
16020